- call +1-201-465-4211
- email sales@mrinsights.biz
The Mendelian disorder is different types of genetic disorder in humans. These genetic disorders are mainly caused by the changes or alterations in a single gene or due to the abnormalities in the genome. These conditions will be present since the child’s birth and can be predicted based on the history of a family with the help of a family tree. This process of analysis is called the pedigree analysis.
Scope of the Report:
This report studies the Mendelian Disorders Testing market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Mendelian Disorders Testing market by product type and applications/end industries.
The different types of Mendelian disorders can be easily determined from the pedigree analysis. Few examples of the Mendelian disorder in humans are Sickle cell anemia, color blindness, muscular dystrophy, Thalassemia, cystic fibrosis, skeletal dysplasia, hemophilia, and phenylketonuria are the most common Mendelian disorders.
The global Mendelian Disorders Testing market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Mendelian Disorders Testing.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Celera Group
Abbott Laboratories
ELITech Group
Quest Diagnostics
AutoGenomics
PerkinElmer
Roche Diagnostics
Bio-Rad Laboratories
Applied Biosystems
Transgenomic
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Carrier Testing
Diagnostic Testing
New-Born Screening
Predictive & Pre-Symptomatic Testing
Prenatal Testing
Market Segment by Applications, can be divided into
Hospitals
Ambulatory Surgical Centers
Specialized Clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Mendelian Disorders Testing Market Overview
1.1 Product Overview and Scope of Mendelian Disorders Testing
1.2 Classification of Mendelian Disorders Testing by Types
1.2.1 Global Mendelian Disorders Testing Revenue Comparison by Types (2017-2023)
1.2.2 Global Mendelian Disorders Testing Revenue Market Share by Types in 2017
1.2.3 Carrier Testing
1.2.4 Diagnostic Testing
1.2.5 New-Born Screening
1.2.6 Predictive & Pre-Symptomatic Testing
1.2.7 Prenatal Testing
1.3 Global Mendelian Disorders Testing Market by Application
1.3.1 Global Mendelian Disorders Testing Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Specialized Clinics
1.4 Global Mendelian Disorders Testing Market by Regions
1.4.1 Global Mendelian Disorders Testing Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Mendelian Disorders Testing Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Mendelian Disorders Testing Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Mendelian Disorders Testing Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Mendelian Disorders Testing Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Mendelian Disorders Testing Status and Prospect (2013-2023)
1.5 Global Market Size of Mendelian Disorders Testing (2013-2023)
2 Manufacturers Profiles
2.1 Celera Group
2.1.1 Business Overview
2.1.2 Mendelian Disorders Testing Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Celera Group Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.2 Abbott Laboratories
2.2.1 Business Overview
2.2.2 Mendelian Disorders Testing Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Abbott Laboratories Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.3 ELITech Group
2.3.1 Business Overview
2.3.2 Mendelian Disorders Testing Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 ELITech Group Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.4 Quest Diagnostics
2.4.1 Business Overview
2.4.2 Mendelian Disorders Testing Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Quest Diagnostics Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.5 AutoGenomics
2.5.1 Business Overview
2.5.2 Mendelian Disorders Testing Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 AutoGenomics Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.6 PerkinElmer
2.6.1 Business Overview
2.6.2 Mendelian Disorders Testing Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 PerkinElmer Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.7 Roche Diagnostics
2.7.1 Business Overview
2.7.2 Mendelian Disorders Testing Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Roche Diagnostics Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.8 Bio-Rad Laboratories
2.8.1 Business Overview
2.8.2 Mendelian Disorders Testing Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Bio-Rad Laboratories Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.9 Applied Biosystems
2.9.1 Business Overview
2.9.2 Mendelian Disorders Testing Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Applied Biosystems Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
2.10 Transgenomic
2.10.1 Business Overview
2.10.2 Mendelian Disorders Testing Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Transgenomic Mendelian Disorders Testing Revenue, Gross Margin and Market Share (2016-2017)
3 Global Mendelian Disorders Testing Market Competition, by Players
3.1 Global Mendelian Disorders Testing Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Mendelian Disorders Testing Players Market Share
3.2.2 Top 10 Mendelian Disorders Testing Players Market Share
3.3 Market Competition Trend
4 Global Mendelian Disorders Testing Market Size by Regions
4.1 Global Mendelian Disorders Testing Revenue and Market Share by Regions
4.2 North America Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
4.3 Europe Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
4.5 South America Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
5 North America Mendelian Disorders Testing Revenue by Countries
5.1 North America Mendelian Disorders Testing Revenue by Countries (2013-2018)
5.2 USA Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
5.3 Canada Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
5.4 Mexico Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
6 Europe Mendelian Disorders Testing Revenue by Countries
6.1 Europe Mendelian Disorders Testing Revenue by Countries (2013-2018)
6.2 Germany Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
6.3 UK Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
6.4 France Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
6.5 Russia Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
6.6 Italy Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Mendelian Disorders Testing Revenue by Countries
7.1 Asia-Pacific Mendelian Disorders Testing Revenue by Countries (2013-2018)
7.2 China Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
7.3 Japan Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
7.4 Korea Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
7.5 India Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
8 South America Mendelian Disorders Testing Revenue by Countries
8.1 South America Mendelian Disorders Testing Revenue by Countries (2013-2018)
8.2 Brazil Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
8.3 Argentina Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
8.4 Colombia Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Mendelian Disorders Testing by Countries
9.1 Middle East and Africa Mendelian Disorders Testing Revenue by Countries (2013-2018)
9.2 Saudi Arabia Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
9.3 UAE Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
9.4 Egypt Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
9.5 Nigeria Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
9.6 South Africa Mendelian Disorders Testing Revenue and Growth Rate (2013-2018)
10 Global Mendelian Disorders Testing Market Segment by Type
10.1 Global Mendelian Disorders Testing Revenue and Market Share by Type (2013-2018)
10.2 Global Mendelian Disorders Testing Market Forecast by Type (2018-2023)
10.3 Carrier Testing Revenue Growth Rate (2013-2023)
10.4 Diagnostic Testing Revenue Growth Rate (2013-2023)
10.5 New-Born Screening Revenue Growth Rate (2013-2023)
10.6 Predictive & Pre-Symptomatic Testing Revenue Growth Rate (2013-2023)
10.7 Prenatal Testing Revenue Growth Rate (2013-2023)
11 Global Mendelian Disorders Testing Market Segment by Application
11.1 Global Mendelian Disorders Testing Revenue Market Share by Application (2013-2018)
11.2 Mendelian Disorders Testing Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Ambulatory Surgical Centers Revenue Growth (2013-2018)
11.5 Specialized Clinics Revenue Growth (2013-2018)
12 Global Mendelian Disorders Testing Market Size Forecast (2018-2023)
12.1 Global Mendelian Disorders Testing Market Size Forecast (2018-2023)
12.2 Global Mendelian Disorders Testing Market Forecast by Regions (2018-2023)
12.3 North America Mendelian Disorders Testing Revenue Market Forecast (2018-2023)
12.4 Europe Mendelian Disorders Testing Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Mendelian Disorders Testing Revenue Market Forecast (2018-2023)
12.6 South America Mendelian Disorders Testing Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Mendelian Disorders Testing Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Mendelian Disorders Testing Picture
Table Product Specifications of Mendelian Disorders Testing
Table Global Mendelian Disorders Testing and Revenue (Million USD) Ma
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
